• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔癌切除术后同步放化疗患者肌肉容积减少对急性口腔黏膜炎的影响

Impact of muscle volume loss on acute oral mucositis in patients undergoing concurrent chemoradiotherapy after oral cancer resection.

作者信息

Yamaguchi T, Makiguchi T, Nakamura H, Yamatsu Y, Hirai Y, Shoda K, Suzuki K, Kim M, Kurozumi S, Motegi S I, Shirabe K, Yokoo S

机构信息

Department of Oral and Maxillofacial Surgery, and Plastic Surgery, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.

Department of Oral and Maxillofacial Surgery, and Plastic Surgery, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.

出版信息

Int J Oral Maxillofac Surg. 2021 Sep;50(9):1195-1202. doi: 10.1016/j.ijom.2020.12.005. Epub 2021 Jan 4.

DOI:10.1016/j.ijom.2020.12.005
PMID:33414037
Abstract

This study evaluated the association between skeletal muscle mass depletion and severe oral mucositis in patients undergoing concurrent chemoradiotherapy after oral cancer resection. Skeletal muscle mass was evaluated in 60 patients using the skeletal muscle index, which was based on skeletal muscle cross-sectional area (on computed tomography) at the level of the third lumbar vertebra. In accordance with the grading criteria of the Radiation Therapy Oncology Group, patients with a grade ≥3 were defined as having severe oral mucositis. Multivariate logistic regression analysis was used to evaluate independent risk factors for severe oral mucositis. Eleven patients (18.3%) were diagnosed with low skeletal muscle mass. Severe oral mucositis occurred in 17 (28.3%) patients, and the mean skeletal muscle index was 42.8 cm/m. A low skeletal muscle mass (hazard ratio 18.1; P=0.001) and a chemotherapy regimen consisting of 5-fluorouracil and cisplatin (versus cisplatin only) (hazard ratio 5.5; P=0.015) were independent risk factors for severe oral mucositis. Future prospective studies are warranted to identify effective pre- and perioperative exercises and nutrition programmes to increase low skeletal muscle mass and reduce the incidence of severe oral mucositis in patients undergoing concurrent chemoradiotherapy after oral cancer resection.

摘要

本研究评估了口腔癌切除术后接受同步放化疗患者的骨骼肌质量消耗与严重口腔黏膜炎之间的关联。使用骨骼肌指数对60例患者的骨骼肌质量进行评估,该指数基于第三腰椎水平的骨骼肌横截面积(通过计算机断层扫描)。根据放射肿瘤学组的分级标准,≥3级的患者被定义为患有严重口腔黏膜炎。采用多因素逻辑回归分析评估严重口腔黏膜炎的独立危险因素。11例患者(18.3%)被诊断为骨骼肌质量低。17例(28.3%)患者发生严重口腔黏膜炎,平均骨骼肌指数为42.8 cm/m²。骨骼肌质量低(风险比18.1;P=0.001)以及由5-氟尿嘧啶和顺铂组成的化疗方案(与仅使用顺铂相比)(风险比5.5;P=0.015)是严重口腔黏膜炎的独立危险因素。有必要开展未来的前瞻性研究,以确定有效的术前和围手术期运动及营养方案,以增加低骨骼肌质量,并降低口腔癌切除术后接受同步放化疗患者严重口腔黏膜炎的发生率。

相似文献

1
Impact of muscle volume loss on acute oral mucositis in patients undergoing concurrent chemoradiotherapy after oral cancer resection.口腔癌切除术后同步放化疗患者肌肉容积减少对急性口腔黏膜炎的影响
Int J Oral Maxillofac Surg. 2021 Sep;50(9):1195-1202. doi: 10.1016/j.ijom.2020.12.005. Epub 2021 Jan 4.
2
Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.头颈部癌症患者同期放化疗中低水平激光治疗预防口腔黏膜炎的 III 期随机研究。
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):270-5. doi: 10.1016/j.ijrobp.2010.10.012. Epub 2010 Dec 14.
3
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.头颈部癌症患者化疗和放疗后唾液细胞因子水平与口腔黏膜炎。
Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):959-966. doi: 10.1016/j.ijrobp.2016.08.047. Epub 2016 Sep 6.
4
[The timing of the appearance of oral mucositis induced by concurrent chemoradiotherapy with S-1 for head and neck cancer].[同步放化疗联合S-1治疗头颈部癌所致口腔黏膜炎的出现时间]
Gan To Kagaku Ryoho. 2014 Dec;41(13):2571-5.
5
A Randomized, Placebo-Controlled Study to Evaluate the Effect of Bio-Enhanced Turmeric Formulation on Radiation-Induced Oral Mucositis.一项评价生物增强型姜黄配方对放射性口腔黏膜炎影响的随机、安慰剂对照研究。
ORL J Otorhinolaryngol Relat Spec. 2022;84(2):103-113. doi: 10.1159/000516577. Epub 2021 Jun 23.
6
Post hoc analysis of a randomized controlled trial comparing concurrent chemoradiation with cisplatin versus nimotuzumab-cisplatin, focusing on acute oral mucositis.一项比较顺铂同期放化疗与尼妥珠单抗-顺铂的随机对照临床试验的事后分析,重点关注急性口腔黏膜炎。
J Egypt Natl Canc Inst. 2021 May 22;33(1):12. doi: 10.1186/s43046-021-00069-1.
7
A traditional Japanese medicine--Hangeshashinto (TJ-14)--alleviates chemoradiation-induced mucositis and improves rates of treatment completion.一种传统日本药物——半夏泻心汤(TJ-14)——可减轻放化疗引起的粘膜炎并提高治疗完成率。
Support Care Cancer. 2015 Jan;23(1):29-35. doi: 10.1007/s00520-014-2315-z. Epub 2014 Jun 19.
8
Factors associated with severe oral mucositis and candidiasis in patients undergoing radiotherapy for oral and oropharyngeal carcinomas: a retrospective multicenter study of 326 patients.接受头颈部放射治疗的口腔和口咽癌患者中与重度口腔黏膜炎和念珠菌病相关的因素:一项回顾性多中心研究,纳入 326 例患者。
Support Care Cancer. 2020 Mar;28(3):1069-1075. doi: 10.1007/s00520-019-04885-z. Epub 2019 Jun 8.
9
Effectiveness of a comprehensive oral management protocol for the prevention of severe oral mucositis in patients receiving radiotherapy with or without chemotherapy for oral cancer: a multicentre, phase II, randomized controlled trial.接受放化疗或单纯放疗治疗口腔癌患者中,综合性口腔管理方案预防重度口腔黏膜炎的有效性:一项多中心、二期、随机对照试验。
Int J Oral Maxillofac Surg. 2019 Jul;48(7):857-864. doi: 10.1016/j.ijom.2018.10.010. Epub 2019 Jan 2.
10
Hospital pharmacist interventions for the management of oral mucositis in patients with head and neck cancer receiving chemoradiotherapy: a multicenter, prospective cohort study.多中心前瞻性队列研究:放化疗治疗头颈部肿瘤患者口腔黏膜炎时,医院药师的干预措施。
Support Care Cancer. 2023 May 3;31(5):316. doi: 10.1007/s00520-023-07784-6.

引用本文的文献

1
Respiratory muscle training reduces painful swallowing and opioid use during radiation therapy for head and neck cancer: a matched pair analysis.呼吸肌训练可减轻头颈癌放疗期间的吞咽疼痛并减少阿片类药物的使用:一项配对分析。
BMC Cancer. 2025 Mar 12;25(1):442. doi: 10.1186/s12885-025-13756-2.
2
Prophylactic pectoralis major flap to compensate for increased risk of pharyngocutaneous fistula in laryngectomy patients with low skeletal muscle mass (PECTORALIS): study protocol for a randomized controlled trial.预防性胸大肌皮瓣以补偿低骨骼肌质量的喉切除术患者咽皮瘘风险增加(PECTORALIS):一项随机对照试验的研究方案。
BMC Cancer. 2024 Jan 15;24(1):76. doi: 10.1186/s12885-023-11773-7.
3
Development and Validation of an Automated Image-Based Deep Learning Platform for Sarcopenia Assessment in Head and Neck Cancer.
基于图像的自动化深度学习平台用于头颈部癌症患者肌肉减少症评估的开发和验证。
JAMA Netw Open. 2023 Aug 1;6(8):e2328280. doi: 10.1001/jamanetworkopen.2023.28280.
4
Role of sarcopenia on survival and treatment-related toxicity in head and neck cancer: a narrative review of current evidence and future perspectives.肌肉减少症对头颈部癌症患者生存和治疗相关毒性的作用:当前证据和未来展望的叙述性综述。
Eur Arch Otorhinolaryngol. 2023 Aug;280(8):3541-3556. doi: 10.1007/s00405-023-08014-9. Epub 2023 May 15.
5
Fully-automated sarcopenia assessment in head and neck cancer: development and external validation of a deep learning pipeline.头颈部癌的全自动肌肉减少症评估:深度学习流程的开发与外部验证
medRxiv. 2023 Mar 6:2023.03.01.23286638. doi: 10.1101/2023.03.01.23286638.
6
Sarcopenia in head and neck cancer: A scoping review.头颈部癌症中的肌肉减少症:范围综述。
PLoS One. 2022 Nov 28;17(11):e0278135. doi: 10.1371/journal.pone.0278135. eCollection 2022.
7
Measurement of Sarcopenia in Head and Neck Cancer Patients and Its Association With Frailty.头颈部癌症患者肌肉减少症的测量及其与衰弱的关联。
Front Oncol. 2022 May 12;12:884988. doi: 10.3389/fonc.2022.884988. eCollection 2022.
8
Natural Products for the Prevention and Treatment of Oral Mucositis-A Review.天然产物防治口腔黏膜炎的研究进展。
Int J Mol Sci. 2022 Apr 15;23(8):4385. doi: 10.3390/ijms23084385.
9
Prospective Evaluation of Sarcopenia in Head and Neck Cancer Patients Treated with Radiotherapy or Radiochemotherapy.接受放疗或放化疗的头颈癌患者肌肉减少症的前瞻性评估
Cancers (Basel). 2021 Feb 11;13(4):753. doi: 10.3390/cancers13040753.